Janssen Pharmaceuticals, Inc. drugs

9 results

Concerta (methylphenidate hydrochloride)

(Methylphenidate hydrochloride)
Janssen Pharmaceuticals, Inc.
Usage: CONCERTA is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 and older, adolescents, and adults up to 65 years of age.

Elmiron (pentosan polysulfate sodium)

(PENTOSAN POLYSULFATE SODIUM)
Janssen Pharmaceuticals, Inc.
Usage: ELMIRON® (pentosan polysulfate sodium) is indicated for relieving bladder pain or discomfort associated with interstitial cystitis.
Janssen Pharmaceuticals, Inc.
Usage: INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of schizophrenia and schizoaffective disorder in adults, both as monotherapy and in combination with mood stabilizers or antidepressants.

Invokamet (canagliflozin and metformin hydrochloride)

(canagliflozin and metformin hydrochloride)
Janssen Pharmaceuticals, Inc.
Usage: INVOKAMET and INVOKAMET XR are indicated as an adjunct to diet and exercise for glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus. Canagliflozin, a component, reduces risks of major cardiovascular events and kidney disease in specific diabetes populations.
Janssen Pharmaceuticals, Inc.
Usage: INVOKANA (canagliflozin) is indicated to improve glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes, reduce cardiovascular event risk in those with established cardiovascular disease, and decrease risks associated with diabetic nephropathy. It is not recommended for type 1 diabetes or severe renal impairment.
Janssen Pharmaceuticals, Inc.
Usage: PONVORY is used to treat relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Janssen Pharmaceuticals, Inc.
Usage: RISPERDAL (risperidone) is indicated for the treatment of schizophrenia, acute manic or mixed episodes of Bipolar I Disorder (as monotherapy or adjunctive therapy), and irritability associated with autistic disorder in children and adolescents. Efficacy is supported by multiple clinical trials in various age groups.
Janssen Pharmaceuticals, Inc.
Usage: SPORANOX (itraconazole) capsules are indicated for treating fungal infections in both immunocompromised and non-immunocompromised patients, including blastomycosis, histoplasmosis, and aspergillosis. It is also used for onychomycosis of toenails and fingernails due to dermatophytes in non-immunocompromised patients.
Janssen Pharmaceuticals, Inc.
Usage: XARELTO is indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing recurrence of these conditions. It also provides prophylaxis for DVT after surgery and reduces cardiovascular and thrombotic event risks in specific patient populations.